Hepatitis A and B Vaccine Dosing Regimens
Hepatitis B Vaccine Options and Dosing
- The Centers for Disease Control and Prevention recommends a standard dosing regimen for hepatitis B vaccination in adults as a 3-dose series administered at 0, 1, and 6 months, while Heplisav-B offers a more convenient 2-dose schedule at 0 and 1 month with comparable efficacy 1, 2
- For adults ≥18 years, Heplisav-B is administered as 20 μg (0.5 mL) per dose in a 2-dose schedule at 0 and 1 month, achieving approximately 90% protective antibody response compared to 70.5%-90.2% with Engerix-B 1, 2
Special Populations
- For hemodialysis patients and immunocompromised adults ≥20 years, the Centers for Disease Control and Prevention recommends Recombivax HB: 40 μg (1.0 mL) per dose in a 3-dose schedule, and Engerix-B: 40 μg (2.0 mL) per dose in a 4-dose schedule at 0, 1, 2, and 6 months 3, 2
- Annual anti-HBs testing and booster doses should be considered for hemodialysis patients when anti-HBs levels decline to <10 mIU/mL, as recommended by the Centers for Disease Control and Prevention 3
Combined Hepatitis A and B Vaccine (Twinrix)
- For adults ≥18 years, Twinrix is administered as a 3-dose series at 0, 1, and 6 months, or a 4-dose accelerated schedule can be used with doses administered on days 0, 7, and 21-30, followed by a booster dose at 12 months, as recommended by the American College of Physicians 4, 5
Interrupted Schedules and Minimum Intervals
- If the hepatitis B vaccine schedule is interrupted, the series does not need to be restarted, and the second dose should be administered as soon as possible, with the second and third doses separated by at least 8 weeks, as recommended by the Centers for Disease Control and Prevention 3
- The minimum interval between the first and second doses is 4 weeks, and the final dose must be administered at least 8 weeks after the second dose and at least 16 weeks after the first dose, as recommended by the Centers for Disease Control and Prevention 3
Response to Vaccination and Revaccination
- After the first dose of hepatitis B vaccine, approximately 30-55% of healthy adults aged <40 years develop protective antibody levels, and after the third dose, >90% of healthy adults aged <40 years develop protective antibody levels, as reported by the Centers for Disease Control and Prevention 6
- The response rate decreases with age, with only about 75% of persons aged 60 years developing protective antibody levels after a complete series, as reported by the Centers for Disease Control and Prevention 6
Common Pitfalls to Avoid
- The Centers for Disease Control and Prevention recommends not restarting the vaccination series if the schedule is interrupted; simply continue where left off, and not assuming serologic testing is required before vaccination; lack of testing should not be a barrier to vaccination 3, 2
- Older adults (>40 years) have lower response rates to hepatitis B vaccination and may require revaccination or higher doses, as reported by the American Geriatrics Society 6, 7
Hepatitis Booster Dose Recommendations
Special Considerations
- The CDC guidelines do not mandate routine booster doses for healthcare workers, but individual institutions may implement monitoring protocols based on local risk assessment, with studies showing 29% of previously vaccinated healthcare workers may have undetectable anti-HBs levels, and booster vaccination consistently producing anamnestic responses 8, 9
Adult Hepatitis B and A Vaccination Guidelines
Hepatitis B Vaccination – Standard Schedules
- Heplisav‑B is administered as 2 doses at month 0 and month 1, achieving roughly 90 % seroprotection in healthy adults. 10
- Engerix‑B, Recombivax HB, and PreHevbrio are given as 3 doses at months 0, 1, and 6. 10
Universal Recommendation (ACIP)
- The 2022 ACIP recommends universal hepatitis B vaccination for all adults aged 19‑59 years, removing the need for risk‑factor screening. 10
Minimum Interval Requirements for the 3‑Dose Series
- Dose 1 → Dose 2: at least 4 weeks. 10
- Dose 2 → Dose 3: at least 8 weeks. 10
- Dose 1 → Dose 3: at least 16 weeks. 10
Handling Interrupted Schedules
- If a series is interrupted, continue the series without restarting; administer the next dose as soon as possible while respecting the minimum intervals (≥8 weeks between doses 2 and 3). [10][11]
- Doses given ≤4 days before the required interval are still considered valid. [10][12]
Special Populations – Modified Dosing
- Hemodialysis or immunocompromised adults require higher antigen doses (40 µg):
- Recombivax HB: 3‑dose schedule (0, 1, 6 months). 10
- Engerix‑B: 4‑dose schedule (0, 1, 2, 6 months). [10][12]
- Heplisav‑B and PreHevbrio have insufficient safety/efficacy data for use in hemodialysis patients or pregnant women. [10][12]
- Pregnant women should receive Engerix‑B, Recombivax HB, or Twinrix (combined HAV/HBV) only. [10][12]
Hepatitis A Vaccination – Standard Schedules
Combined Hepatitis A + B Vaccine (Twinrix)
- Standard schedule: 3 doses at months 0, 1, and 6. [10][12]
- Accelerated schedule (useful for travelers needing rapid protection): 4 doses on days 0, 7, 21‑30, with a booster at month 12. [10][12]
- The 4‑day grace period does not apply to the first three accelerated doses; if a dose is missed, give it as soon as possible without restarting the series. [10][12]
Practical Pitfalls & Contraindications
- Never restart an interrupted hepatitis B or Twinrix series; this wastes doses and delays immunity. [10][11]
- Do not administer the third hepatitis B dose before 16 weeks from the first dose, even if 8 weeks have passed since the second dose. 10
- Standard adult doses are inappropriate for hemodialysis patients—use the higher 40 µg formulations. 10
- Avoid Heplisav‑B and PreHevbrio in pregnant women and hemodialysis patients due to limited safety data. [10][12]
- Serologic testing is not required before initiating vaccination; lack of testing should not be a barrier. 10